Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Smurfit WestRock plc Ordinary Shares (SW) vs 10X Genomics Inc (TXG) Price & Performance

Smurfit WestRock plc Ordinary SharesTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Smurfit WestRock plc Ordinary Shares vs 10X Genomics Inc — how do they compare? Smurfit WestRock plc Ordinary Shares trades at $41.51 (market cap $21.66B), while 10X Genomics Inc trades at $79.65 (market cap $9.92B). The key difference: Smurfit WestRock plc Ordinary Shares is far larger — about 2.2× 10X Genomics Inc's market cap, and Smurfit WestRock plc Ordinary Shares pays a 4.38% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smurfit WestRock plc Ordinary Shares for 0 Days and 10X Genomics Inc for 92 Days on average.

SWTXG
Market Cap
$21.66B$9.92B
Volume
3,627,3289,372,166
Sector
Consumer CyclicalHealth
52-Week High
$51.84$97.74
52-Week Low
$32.79$11.48
Typical Hold Time
0 Days92 Days
Enterprise Value
$35.14B$9.44B
Dividend Yield
4.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Smurfit WestRock plc Ordinary Shares

No Aura AI signal available yet.

10X Genomics Inc

10x Genomics (TXG) trades at $77.28, down 4.19% on the day, amid a bearish technical signal. The company reported revenue of $642.82M in 2025, with a net loss of $43.54M, though it has beaten EPS estimates for three consecutive quarters. Recent news highlights the launch of its Atera spatial biology platform and a patent victory, signaling innovation and market strength. Cash flow from operations improved to $136.05M in 2025, indicating better operational efficiency.

The outlook is cautiously optimistic, with strong product demand and improving margins offering upside potential. However, persistent losses, high valuation multiples, and competitive pressures present significant risks. Analyst consensus is mixed, with a $74.30 price target slightly below the current price, reflecting uncertainty about near-term profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SW
100% Buy0% Sell
Avg holding period · 0 Days
TXG
4% Buy96% Sell
Avg holding period · 92 Days

Top news

Latest headlines on both assets

About Smurfit WestRock plc Ordinary Shares

Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.

Read more on SW →

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG →